FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Amerisource Health Services BuPROPion Hydrochloride Tablets Recall

BuPROPion Hydrochloride Tablets, USP 75 mg, 100 Tablets (10 x 10) per carton, Rx Only,…

Amerisource Health Services LLC · Columbus, OH

Risk level
Class II
Reported by FDA
Feb 22, 2023
Recall ID
D-0328-2023
Check your lot numberHow we source this data

Summary

Amerisource Health Services recalled BuPROPion Hydrochloride Tablets starting Dec 27, 2022. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0328-2023 on Feb 22, 2023. Reason: Failed Impurities/Degradation Specifications. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation Specifications

Product description

BuPROPion Hydrochloride Tablets, USP 75 mg, 100 Tablets (10 x 10) per carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC carton: 60687-340-01; NDC Blister Pack: 60687-340-11

Lot numbers, UPCs & expiration codes

Lot #: 1003837, Exp. Date 01/31/2023

Where it was sold

Nationwide within the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0328-2023
Classification
Class II
Status
Terminated
Recall initiated
Dec 27, 2022
FDA report date
Feb 22, 2023
Quantity
1,416 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
Amerisource Health Services LLC

Original FDA data

Every field from FDA enforcement report D-0328-2023, exactly as published.

Show all FDA fields
City
Columbus
State
OH
Status
Terminated
Country
United States
Event ID
91609
Address
2550 John Glenn Ave Ste A
Code information
Lot #: 1003837, Exp. Date 01/31/2023
Postal code
43217-1188
Report date
Feb 22, 2023
Product type
Drugs
Recall number
D-0328-2023
Classification
Class II
Recalling firm
Amerisource Health Services LLC
Product quantity
1,416 cartons
Termination date
Aug 4, 2023
Reason for recall
Failed Impurities/Degradation Specifications
Voluntary / mandated
Voluntary: Firm initiated
Product description
BuPROPion Hydrochloride Tablets, USP 75 mg, 100 Tablets (10 x 10) per carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC carton: 60687-340-01; NDC Blister Pack: 60687-340-11
Distribution pattern
Nationwide within the USA
Recall initiation date
Dec 27, 2022
Initial firm notification
Letter
Center classification date
Feb 16, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0328-2023, published Feb 22, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls